Quick Facts at a Glance
- Recall Date
- October 9, 2025
- Hazard Level
- HIGH
- Brand
- STAQ Pharma
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- STAQ Pharma
- Product type
- Ketamine Hydrochloride Injection (IV)
- Model numbers
- 25156673A
- Sizes
- 50 mL
- Sold at
- Multiple Retailers
- Where affected
- ALL
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
October 9, 2025
Reported by FDA DRUG
October 22, 2025
RecallRadar source check
April 18, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
Labeling: Incorrect or Missing Lot and/or Exp Date
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact STAQ Pharma, Inc. or your healthcare provider for guidance. Notification method: Letter
About This Product
Ketamine Hydrochloride injection is used in clinical settings as an anesthetic or analgesic adjunct. The product is supplied in a 50 mL syringe with labeled strength of 50 mg per 5 mL.
Why This Is Dangerous
The defect is labeling. Incorrect or missing lot and expiration date information can hinder traceability and dosing accuracy, potentially affecting patient safety.
Industry Context
This recall is not described as part of a broader industry pattern in the notice.
Real-World Impact
Healthcare providers must verify labeling before use. The recall can create administrative burden and potential delays in patient care while traces are completed.
Practical Guidance
How to identify if yours is affected
- Check NDC 73177-0156-02 on the packaging.
- Check Lot number for 25156673A.
- Check Expiry date for 02FEB2026.
Where to find product info
FDA enforcement page link and STAQ Pharma recall communications. Manufacturer address: 14135 E 42nd Ave, Denver, CO.
What timeline to expect
No specific timeline provided for resolution or refunds. Follow STAQ Pharma guidance.
If the manufacturer is unresponsive
- Document all attempts to contact STAQ Pharma.
- File a complaint with FDA MedWatch if necessary.
- Consult state pharmacy board for guidance.
How to prevent similar issues
- Implement a labeling verification step for all drug lots before distribution.
- Cross-check lot and expiry against the product at point of care.
- Train staff to escalate labeling discrepancies immediately.
Documentation advice
Keep a copy of the recall notice, record lot 25156673A and expiry 02FEB2026, and save all correspondence with the manufacturer.
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Product Details
Ketamine Hydrochloride, 50 mg/5 mL (10 mg/mL), in a 50 mL syringe. Brand STAQ Pharma Inc. NDC 73177-0156-02. Lot 25156673A. Expiry 02FEB2026. Distributed nationwide in the U.S.
Reported Incidents
No injuries or incidents have been reported.
Key Facts
- 50 mg/5 mL (10 mg/mL)
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.
